Blau Farmaceutica SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Blau Farmaceutica SA with three other
pharmaceutical manufacturers in Latin America:
Laboratorios Richmond SACIF
sales of 6.18 billion Argentinian Pesos [US$62.74 million]
of which 66%
was Private Market),
(4.09 billion Brazilian Reals [US$773.08 million]
Ouro Fino Saude Animal Participacoes SA
(730.11 million Brazilian Reals [US$138.04 million]
of which 74%
was Production Animals).
During the second
quarter of 2021, sales at Blau Farmaceutica SA totalled
370.76 million Brazilian Reals.
an increase of 15.1%
from the 322.12 million Brazilian Reals in sales at the company during the second quarter of 2020.
During the first two
quarters of 2021, sales totalled 696.89 million Brazilian Reals, which is
than through the first two quarters of 2020.
During the previous 6 quarters, sales at Blau Farmaceutica SA have increased compared with the same quarter in the previous year.
During the year ended December of 2020, sales at
Blau Farmaceutica SA were 1.18 billion Brazilian Reals (US$223.44 million).
increase of 20.9%
versus 2019, when the company's sales were 977.50 million Brazilian Reals.
This was the fifth consecutive year of sales increases at Blau Farmaceutica SA
(and since 2015, sales have increased a total of 208%).
Sales of Hospital saw an increase
22.8% in 2020, from
907.97 million Brazilian Reals to 1.12 billion Brazilian Reals.
Not all segments of Blau Farmaceutica SA experienced an increase in sales in 2020:
sales of Pharmacy fell 4.3% to 66.53 million Brazilian Reals.